Natural, Synthetic or Repurposed Anticancer and Antiviral Drugs to Treat Challenging Diseases

Dear Colleagues,

With this Special Issue of Process, we aim to summarize the current trends in the repurposing, drug discovery and development field, while reporting new antiviral and anticancer drugs as promising candidates for the treatment of life-threatening diseases of public health interest, such as COVID-19 and various types of cancers, as well as new strategies and computational methods that can help us design and manufacture drugs in a more accurate, low-costs and highly efficient way, using natural to synthetic resources. COVID-19 and cancers, which continue to disrupt daily life, request more accurate and safe data, new effective vaccines and “savior” protocols, based on marketed antiviral or anticancer drugs, or using natural resources to support decisions for therapeutic options with reduced side-effects on human health.

In this regard, we cordially invite all researchers working in the field to submit original research papers, reviews and any other accepted types of articles to this Special Issue of Processes, reporting the most recent approaches on the design and development of new antiviral and anticancer drugs by employing various innovative and advanced computational methods and tools, new protocols, new targets, new chemical structures, new experimental data, etc. Submission of manuscripts describing the negative results as the final outcome of a robust working strategy is also encouraged.

Dr. Alina Bora
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Processes is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2400 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.